Home
IPO Review by Dilip Davda
Menu
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Pages
Home
IPO Review by Dilip Davda
Categories
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Tag:
Pharmaceutical Industry
India Inc
Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter
Team Finance Intellect
—
May 29, 2019
comments off
Drug major Sun Pharmaceutical Industries on Tuesday recorded a 53% decline in consolidated net profit at ₹636 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit...
Read more »